Edition:
India

DURECT Corp (DRRX.OQ)

DRRX.OQ on NASDAQ Stock Exchange Capital Market

0.68USD
16 Jul 2019
Change (% chg)

$-0.00 (-0.69%)
Prev Close
$0.68
Open
$0.68
Day's High
$0.68
Day's Low
$0.68
Volume
5,547
Avg. Vol
305,166
52-wk High
$1.68
52-wk Low
$0.48

About

Durect Corporation is a biopharmaceutical company with research and development programs. The Company's products candidates include DUR-928, oral for metabolic/lipid disorders, and DUR-928, injectable for acute organ injuries. Its other product candidates include POSIMIR (controlled release injection of bupivacaine), REMOXY... (more)

Overall

Beta: 1.82
Market Cap(Mil.): $130.98
Shares Outstanding(Mil.): 191.30
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates